secwatch.observer — SEC 8-K summary
======================================

Issuer:     ONCOSEC MEDICAL Inc (—)
CIK:        0001444307
Form:       8-K
Filed at:   2022-12-28T23:59:59+00:00
Accession:  0001493152-22-036682
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

OncoSec receives Nasdaq delisting notice for negative equity of $(984,449)
--------------------------------------------------------------------------

- Stockholders' equity was $(984,449) as of Oct 31, 2022, below Nasdaq's $2.5M minimum.
- Company has until Feb 10, 2023 to submit a compliance plan; if accepted, up to 180 days to regain compliance.
- Failure to regain compliance could lead to delisting, reduced liquidity, and impaired financing.
- OncoSec is evaluating options and intends to submit a plan to Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444307/000149315222036682/0001493152-22-036682-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444307/000149315222036682/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-036682

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer